Answers are grounded in this paper and cite their sources.
Mary Moran and colleagues discuss the best strategies for African regulators to be supported in their efforts to evaluate and approve drugs for their own populations.
No takes yet. Share an insight, caveat, or question.
Moran et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: